scholarly journals INR and vitamin K antagonists management by the primary care physicians in Normandy

2020 ◽  
Vol 78 (2) ◽  
pp. 157-173
Author(s):  
Loïc Druilhe ◽  
Xavier Humbert
Keyword(s):  
Primary Care ◽  
Vitamin K ◽  
Primary Care Physicians ◽  
Vitamin K Antagonists

Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study

2018 ◽  
pp. 764-769 ◽  
Author(s):  
Jolanta Sawicka-Powierza ◽  
Krzysztof Buczkowski ◽  
Sławomir Chlabicz ◽  
Zbigniew Gugnowski ◽  
Katarzyna Powierza ◽  
...  
Keyword(s):  
Primary Care ◽  
Quality Control ◽  
Vitamin K ◽  
Oral Anticoagulation ◽  
Vitamin K Antagonists ◽  
Multi Centre Study ◽  
Centre Study ◽  
Primary Care Patients

Anticoagulation quality control in Primary Care with vitamin K antagonists

2017 ◽  
Vol 148 (12) ◽  
pp. 571-572
Author(s):  
Juan Carlos Aguirre Rodriguez ◽  
Manuel Jimenez de la Cruz ◽  
Abraham Hidalgo Rodríguez
Keyword(s):  
Primary Care ◽  
Quality Control ◽  
Vitamin K ◽  
Vitamin K Antagonists

scholarly journals Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey

BJGP Open ◽  
2018 ◽  
Vol 2 (3) ◽  
pp. bjgpopen18X101602
Author(s):  
Claudio Cimminiello ◽  
Robert Hatala ◽  
Sami Pakarinen ◽  
Hernan Polo Friz ◽  
David Fitzmaurice ◽  
...  
Keyword(s):  
Primary Care ◽  
Vitamin K ◽  
Primary Care Physicians ◽  
Information Needs ◽  
Oral Anticoagulants ◽  
Care Physician ◽  
Vitamin K Antagonist ◽  
Public Health Issue ◽  
Learning Needs ◽  
Self Assessment

BackgroundFamiliarity and competency in the options for stroke prevention in atrial fibrillation (AF) and the role of non-vitamin K antagonist oral anticoagulants (NOACs) may vary among primary care physicians (PCPs) from different European countries.AimsTo investigate PCP views on prescribing and managing NOACs across Europe and identify perceived unmet needs.Design & settingWeb-based survey including PCPs with particular interest in cardiovascular medicine.MethodA questionnaire was drawn up, containing 10 questions on initiation and ongoing management of NOACs; use of AF stroke guidelines on NOACs and anticoagulant switching; and perceived information needs.ResultsThe overall response rate was 42%. The majority of PCPs declared they are responsible for and confident in both initiating and managing NOAC therapy. In some countries, PCPs are not able to initiate NOAC therapy due to administrative barriers (namely, Italy and Slovakia). No single set of guidelines is referred to across all countries and over a fifth of responders indicate they do not follow specific guidelines. The main learning needs reported were more related to initiation than to ongoing management of anticoagulant therapy.ConclusionAccording to this self-assessment survey, the experience of most PCPs in management of different aspects of AF appears good and only some felt the need for further training. However, in the light of the importance of this topic as public health issue, intensified efforts aiming at better equipping PCPs to meet their key roles in an integrated service across Europe are overdue.

Fool’s Gold: Psychologists Using Disingenuous Reasoning to Mislead Legislatures into Granting Psychologists Prescriptive Authority

2003 ◽  
Vol 29 (4) ◽  
pp. 489-524
Author(s):  
Brent Pollitt
Keyword(s):  
Primary Care ◽  
Mental Illness ◽  
Nurse Practitioners ◽  
Primary Care Physicians ◽  
American Psychological Association ◽  
The United States ◽  
Psychotropic Medications ◽  
American Psychological ◽  
Training Requirements ◽  
Prescriptive Authority

Mental illness is a serious problem in the United States. Based on “current epidemiological estimates, at least one in five people has a diagnosable mental disorder during the course of a year.” Fortunately, many of these disorders respond positively to psychotropic medications. While psychiatrists write some of the prescriptions for psychotropic medications, primary care physicians write more of them. State legislatures, seeking to expand patient access to pharmacological treatment, granted physician assistants and nurse practitioners prescriptive authority for psychotropic medications. Over the past decade other groups have gained some form of prescriptive authority. Currently, psychologists comprise the primary group seeking prescriptive authority for psychotropic medications.The American Society for the Advancement of Pharmacotherapy (“ASAP”), a division of the American Psychological Association (“APA”), spearheads the drive for psychologists to gain prescriptive authority. The American Psychological Association offers five main reasons why legislatures should grant psychologists this privilege: 1) psychologists’ education and clinical training better qualify them to diagnose and treat mental illness in comparison with primary care physicians; 2) the Department of Defense Psychopharmacology Demonstration Project (“PDP”) demonstrated non-physician psychologists can prescribe psychotropic medications safely; 3) the recommended post-doctoral training requirements adequately prepare psychologists to prescribe safely psychotropic medications; 4) this privilege will increase availability of mental healthcare services, especially in rural areas; and 5) this privilege will result in an overall reduction in medical expenses, because patients will visit only one healthcare provider instead of two–one for psychotherapy and one for medication.

1566: BPH Management in an HMO Setting: Differences between Primary Care Physicians and Urologists

2007 ◽  
Vol 177 (4S) ◽  
pp. 517-517
Author(s):  
John M. Hollingsworth ◽  
Stephanie Daignault ◽  
Brent K. Hollenbeck ◽  
John T. Wei
Keyword(s):  
Primary Care ◽  
Primary Care Physicians
Sign in / Sign up

Export Citation Format

Share Document